High frequency of BRCA1 and BRCA2 germline mutations in Ashkenazi Jewish ovarian cancer patients, regardless of family history

Gynecologic Oncology

Volumn 67, Issue 2, 1997, Pages 123-126

  Beller, Uziel ^a   Halle, David ^a   Catane, Raphael ^a   Kaufman, Bella ^a   Hornreich, Gila ^a   Levy Lahad, Ephrat ^a  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CLINICAL ARTICLE; ENVIRONMENTAL FACTOR; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GERM LINE; HIGH RISK POPULATION; HUMAN; JEW; OVARY CANCER; PENETRANCE; PRIORITY JOURNAL;

EID: 0031281949     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1997.4844     Document Type: Article

References (28)

1. Jacobs I. Genetic, biochemical, and multimodal approaches to screening for ovarian cancer. Gynecol Oncol. 55:1994;S22-27.
2. Hall J M, Lee M K, Morrow J, Newman B, Anderson L A, Huey B, King M C. Linkage of early-onset familial breast cancer to chromosome 17q21. Science. 250:1990;1684-1689.
3. Wooster R, Neuhausen S L, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, Seal S, Tran T, Averill D, Fields P, Marshall G, Narod S, Lenior G M, Lynch H, Feunteun J, Devilee P, Cornelisse C J, Menko F H, Daly P A, Ormiston W, McManus R, Pye C, Lewis C M, Cannon-Albright L A, Peto J, Ponder D AJ, Skolnick M H, Easton D, Goldgar D, Stratton M R. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science. 265:1994;2088-2090.
4. Miki Y, Swensen J, Shattuck-Eidens D, Futreal P A, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett L M, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow P K, Norris F H, Helvering L, Morrison P, Rosteck P, Lai M, Barrett J C, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick M H. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 266:1994;66-71.
5. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumb C, Micklem G, Barfoot R, Hamoudi R, Patel S, Rice K, Biggs P, Smith A, Connor F, Arason A, Gundmundsson J, Kelsell D, Ford D, Tonin P, Bishop D T, Spurr N K, Ponder D AJ, Eeles R, Peto J, Devilee P, Lynch H, Narod S, Lenoir G, Easton D F, Egilsson V, Barkadottir R B, Benrley D R, Futreal P A, Ashworth A, Stratton M R. Identification of the breast cancer susceptibility gene BRCA2. Nature. 378:1995;789-792.
6. Easton D F, Bishop D T, Ford D, Cockford G P. Genetic linkage analysis in familial breast and ovarian cancer. Am J Hum Genet. 52:1993;718-722.
7. Ford D, Easton D F, Bishop D T, Narod S A, Goldgar D E. Risks of cancer in BRCA1-mutation carriers. Lancet. 343:1994;692-695.
8. Shattuck-Eidens D, McClure M, Simard J, Labrie F, Narod S, Couch F, Weber B, Castilla L, Brody L, Friedman L, Ostermeyer E, Szabo C, King M C, Jhanwar S, Offit K, Norton L, Gilewski T, Lubin M, Osborne M, Black D, Boyd M, Steel M, Ingles S, Haile R, Lindblom A, Borg, Bishop D T, Solomon E, Radice P, Spatti G, Gayther S, Ponder B, Warren W, Stratton M, Liu Q, Fujimura F, Lewis C, Skolnick M H, Goldgar D E. A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene: Implications for presymptomatic testing and screening. J Am Med Assoc. 273:1995;535-541.
9. Fitzgerald M, MacDonald D J, Krainer M, Hoover I, O'Neil E, Unsal H, Silva-Arrieto S, Finkelstein D, Beer-Romero P, Englert C, Sgroi D C, Smith B L, Younger J W, Garber J E, Duda R B, Mayzel K A, Isselbacher K J, Friend S H, Haber D A. Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. New Engl J Med. 334:1996;143-149.
10. Friedman L S, Szabo C I, Ostermeyer E A, Dowd P, Butler L, Park T, Lee M K, Goode E, Rowell S E, King M-C. Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation in Ashkenazi Jewish families. Am J Hum Genet. 57:1995;1284-1297.
11. Offit K, Gilewski T, McGuire P, Schluger A, Brown K, Neuhausen S, Skolnick M, Norton L, Goldgar D. Germline BRCA1 mutations in Jewish women affected by breast cancer. Lancet. 1996.
12. Simard J, Tonin P, Durocher F, Morgan K, Rommens J, Gingras S, Samson C, Leblanc J-F, Belanger C, Dion F, Liu Q, Skolnick M, Goldgar D, Shattuck-Eidens D, Labrie F, Narod S A. Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nature Genet. 8:1994;392-398.
13. Takahashi H, Behbakht K, McGovern P E, Chiu H C, Couch F J, Weber B L, Friedman L S, King M-C, Furusato M, LiVolsi V A, Menzin A, Liu P, Benjamin I, Morgan M A, King S A, Rebane B A, Cardonick A, Mikuta J J, Rubin S C, Boyd J. Mutation analysis of the BRCA1 gene in ovarian cancers. Cancer Res. 55:1995;2998-3002.
14. Tonin P, Serova O, Lenoir G, Lynch H, Durocher F, Simard J, Morgan K, Narod S. BRCA1 mutations in Ashkenazi Jewish women. Am J Hum Genet. 57:1995;189.
15. Couch F J, Farid L M, DeShano M L, Tavtigian S V, Calzone K, Campeau L, Peng Y, Bogden B, Chen Q, Neuhausen S, Shattuck-Eidens D, Godwin A K, Daly M, Radford D M, Sedlacek S, Rommens J, Simard J, Garber J, Merajver S, Weber B L. BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nature Genet. 13:1996;123-125.
16. Neuhausen S, Gilewski T, Norton L, Tran T, McGuire P, Swensen J, Hampel H, Borgen P, Brown K, Skolnick M, Shattuck-Eidens D, Jhanwar S, Goldgar D, Offit K. Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Nature Genet. 13:1996;126-128.
17. Motulsky A G. Jewish diseases and origins. Nature Genet. 9:1995;99-101.
18. Friedman L S, Ostermeyer E A, Szabo C I, Dowd P, Lynch E D, Rowell S E, King M-C. Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nature Genet. 8:1994;399-404.
19. Neuhausen S, Mazoyer S, Friedman L, Offit K, Jahnwar S, Gilewski T, Colegio A, Tomlinson G, Cannon-Albright L, Skolnick M, Stratton M, Easton D, Bishop T, Kelsall D, Weber B, Couch F, Ponder B, Stoppa-Lyonnet D, Narod S, King M-C, Goldgar D. Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: Results of an international study. Am J Hum Genet. 58:1995;271-280.
20. Oddoux C, Struewing J P, Clayton C M, Neuhausen S, Brody L C, Kaback M, Haas B, Norton L, Borgen P, Jhanwar S, Goldgar D, Ostrer H, Offit K. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nature Genet. 14:1996;188-190.
21. Tonin P, Weber B, Offit K, Couch F, Rebbeck T R, Neuhuasen S, Godwin A K, Daly M, Wagner-Costalos J, Berman D, Grana G, Fox E, Kane M F, Kolodner R D, Krainer M, Haber D A, Struewing J P, Warner E, Rosen B, Lerman C, Peshkin B, Norton L, Serova O, Foulkes W D, Lynch H T, Lenoir G M, Narod S A, Garber J E. Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nature Med. 2:1996;1179-1183.
22. Roa B B, Boyd A A, Volcik K, Richards C S. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nature Genet. 14:1996;185-187.
23. Struewing J P, Abeliovich D, Peretz T, Avishai N, Kaback M M, Collins F S, Brody L C. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nature Genet. 11:1995;198-200.
24. Ganguly A, Rock M J, Prockop D J. Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double stranded PCR products and DNA fragments: Evidence for solvent induced bends in DNA heteroduplexes. Proc Natl Acad Sci U.S.A. 90:1993;10,325-10,329.
25. Modan B, Gak E, Bar Sade-Bruchim R, Hirsh-Yechezkel G, Theodor L, Lubin F, Ben-Baruch G, Beller U, Fishman A, Dgani R, Menczer J, Papa M, Friedman E. High frequency of BRCA1 185delAG mutation in ovarian cancer in Israel. J Am Med Assoc. 276:1996;1823-1825.
26. Rubin S C, Benjamin I, Behbakht K, Takahashi H, Morgan M A, LiVolsi V A, Berchuck A, Muto M G, Garber J E, Weber B L, Lynch H T, Boyd J. Clinical and pathological features of ovarian cancer in women with germline mutations of BRCA1. New Engl J Med. 335:1996;1413-1416.
27. Burke W, Daly M, Garber J, Botkin J, Kahn M JE, Lynch P, McTiernan A, Offit K, Perlman J, Petersen G, Thomson E, Varricchio C. Recommendations for follow-up care of individuals with an inherited predisposition to cancer: II. BRCA1 and BRCA2. J Am Med Assoc. 277:1997;997-1003.
28. Levy-Lahad E, Catane R, Eisenberg S, Kaufman B, Hornreich G, Lishinsky E, Shohat M, Weber B L, Beller U, Lahad A, Halle D. Recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: Frequency and differential penetrance in ovarian cancer and in breast and ovarian cancer families. Am J Hum Genet. 60:1997;1059-1067.